0001782107 false 0001782107 2023-09-02 2023-09-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 2, 2023

 

Blue Water Biotech, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41294   83-2262816
(State or other jurisdiction of
incorporation or organization)		   (Commission file number)  

(IRS Employer

Identification No.)

 

201 E. Fifth Street, Suite 1900

Cincinnati, Ohio 45202

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (513) 620-4101

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.00001 per share   BWV   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective as of September 2, 2023, Vuk Jeremić resigned as a member of the Board of Directors (the “Board”) of Blue Water Biotech, Inc. (the “Company”) as well as from his positions as a member of the Compensation Committee and Nominating and Corporate Governance Committee of the Board. Mr. Jeremić’s departure was not the result of any disagreement with management or the Board on any matter relating to the Company’s operations, policies or practices.

  

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Blue Water Biotech, Inc.
     
  By: /s/ Jon Garfield
    Name:  Jon Garfield
    Title: Chief Financial Officer
     
Dated: September 8, 2023    

  

 

 

 

 

 

v3.23.2
Cover
Sep. 02, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 02, 2023
Entity File Number 001-41294
Entity Registrant Name Blue Water Biotech, Inc.
Entity Central Index Key 0001782107
Entity Tax Identification Number 83-2262816
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 201 E. Fifth Street
Entity Address, Address Line Two Suite 1900
Entity Address, City or Town Cincinnati
Entity Address, State or Province OH
Entity Address, Postal Zip Code 45202
City Area Code (513)
Local Phone Number 620-4101
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.00001 per share
Trading Symbol BWV
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Grafico Azioni Blue Water Biotech (NASDAQ:BWV)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Blue Water Biotech
Grafico Azioni Blue Water Biotech (NASDAQ:BWV)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Blue Water Biotech